Premium functions are now FREE OF CHARGE due to the modification of the investment data Data developments may cause some parts work incorrectly Incorrect sections - Financial statements, Earnings upcoming dates and calendars Please take our apologise. It will be fixed soon

REGN - Regeneron Pharmaceuticals, Inc.

IEX Last Trade
1184.19
5.260   0.444%

Share volume: 405,349
Last Updated: Fri 30 Aug 2024 09:59:59 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): 0.21%

PREVIOUS CLOSE
CHG
CHG%
$1,178.93
5.26
0.45%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
57%
Profitability 68%
Dept financing 7%
Liquidity 72%
Performance 54%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-1.20%
1 Month
9.92%
3 Months
22.14%
6 Months
19.96%
1 Year
41.89%
2 Year
101.34%
Key data
Stock price
$1,184.19
P/E Ratio 
29.72
DAY RANGE
N/A - N/A
EPS 
$37.79
52 WEEK RANGE
$769.19 - $1,211.20
52 WEEK CHANGE
$0.42
MARKET CAP 
128.441 B
YIELD 
N/A
SHARES OUTSTANDING 
108.417 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/31/2024
BETA 
0.59
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$350,066
AVERAGE 30 VOLUME 
$453,504
Company detail
CEO: Leonard Schleifer
Region: US
Website: https://www.regeneron.com/
Employees: 12,099
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.

Recent news